These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21047207)
41. Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors. Nashan B Transpl Int; 2004 Jul; 17(6):279-85. PubMed ID: 15221123 [TBL] [Abstract][Full Text] [Related]
42. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517 [TBL] [Abstract][Full Text] [Related]
43. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603 [TBL] [Abstract][Full Text] [Related]
44. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity. Campistol JM; Grinyó JM Transplantation; 2001 Jun; 71(11 Suppl):SS42-51. PubMed ID: 11583488 [TBL] [Abstract][Full Text] [Related]
50. Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation. Lee SH; Kim BC; Yang DH; Park MS; Choi SM; Kim MK; Cho KH J Neurol; 2008 Jun; 255(6):929-31. PubMed ID: 18458866 [No Abstract] [Full Text] [Related]
51. Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome. Sinha A; Sharma A; Mehta A; Gupta R; Gulati A; Hari P; Dinda AK; Bagga A Indian J Nephrol; 2013 Jan; 23(1):41-6. PubMed ID: 23580804 [TBL] [Abstract][Full Text] [Related]
52. Nephrotoxicity of Calcineurin Inhibitors in Kidney Epithelial Cells is Independent of NFAT Signaling. Karolin A; Escher G; Rudloff S; Sidler D Front Pharmacol; 2021; 12():789080. PubMed ID: 35140605 [No Abstract] [Full Text] [Related]
53. A Review on Drug-Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches. Mody H; Ramakrishnan V; Chaar M; Lezeau J; Rump A; Taha K; Lesko L; Ait-Oudhia S Clin Pharmacol Drug Dev; 2020 Nov; 9(8):896-909. PubMed ID: 33025766 [TBL] [Abstract][Full Text] [Related]
54. Electrolyte and Acid-base disturbances induced by clacineurin inhibitors. Lee CH; Kim GH Electrolyte Blood Press; 2007 Dec; 5(2):126-30. PubMed ID: 24459511 [TBL] [Abstract][Full Text] [Related]
55. The epidemiology of drug-induced disorders: the kidney. Taber SS; Pasko DA Expert Opin Drug Saf; 2008 Nov; 7(6):679-90. PubMed ID: 18983215 [TBL] [Abstract][Full Text] [Related]
56. The use of urinary enzymes as markers of nephrotoxicity. Dubach UC; Le Hir M; Gandhi R Pol Arch Med Wewn; 1988 Nov; 80(5):283-9. PubMed ID: 3078211 [No Abstract] [Full Text] [Related]
57. [(Immuno‑)Pathology of drug side effects in the kidney]. Pfister F; Büttner-Herold M; Amann K Pathologe; 2018 Nov; 39(6):576-582. PubMed ID: 30167781 [TBL] [Abstract][Full Text] [Related]